Main > PHARMA. > Drug BioAvailability > Oral Drug BioAvailability > Improvement. > Essential Oils (USA.A) > Patent > Literature (Claims Etc.) > Claim 1: Oral BioAvailability of > Hydrophobic Drug Increase Method: > Co-Adm. Drug & Essential Oil or > Essential Oil Component to provide > Concn. of Essential Oil or Comp. in > Gut > than Concn. that Reduces > Cyclosporin (C) to Hydroxylated (C > ) Conversion by 10% in Assay Contg. > Rat Liver Microsomes (250 .mu.g) > Cyclosporin (1 .mu.M), > & NADPH (1 mM) in > Sodium Phosphate Buffer (1 ml 0.1M)

---

Sodium Phosphate Buffer (1 ml 0.1M)'s subsections
pH = 7.4. Claim 3: Pharma. Compn.:
pH = 7.4. Claim 7: Pharma. Compn.:

Sodium Phosphate Buffer (1 ml 0.1M)'s products
This section has no products